A key mechanism that explains how compounds they're developing can suppress schizophrenia-like symptoms in mice without side effects has been discovered by researchers. An estimated 3 million Americans have schizophrenia, which is associated with excessive amounts of the neurotransmitter dopamine in a part of the forebrain called the striatum.